Almhagen E, Alkhiat A, Sorcini B, Alpsten F, Kronborg CJS, Rønde HS, Guren MG, Pilskog S, Valdman A (2025)
An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer
Cancers (Basel), 17 (16)
DOI 10.3390/cancers17162627, PubMed 40867256

Slørdahl KS, Skovlund E, Olsen JÅ, Tvedt R, Thomsen M, Kaasa S, Guren MG (2025)
Patient-reported outcomes after chemoradiotherapy for anal cancer
Acta Oncol, 64, 1005-1013
DOI 10.2340/1651-226X.2025.43636, PubMed 40734575

Chen IM, Johansen JS, Theile S, Silverman LM, Pelz KR, Madsen K, Dajani O, Lim KZM, Lorentzen T, Gaafer O, Koniaris LG, Ferreira AC, Neelon B, Guttridge DC, Ostrowski MC, Zimmers TA, Nielsen D (2025)
Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia
J Clin Oncol, 43 (25), 2840
DOI 10.1200/JCO-25-01631, PubMed 40700669